In 2006, inspired by NSC culture conditions, the Fine lab used serum-free, EGF/FGF-2-supplemented Neurobasal medium to cultivate primary glioma cells and found that these cells remained more similar to the parental tumors than those cultured in serum-containing DMEM medium [27]. Here, FGF2 is linked to glioma.